Atrial fibrillation and chronic kidney disease: main clinical characteristics of patients in selected subjects of the Russian Federation
Open Access
- 9 May 2023
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 22 (4) , 3544
Abstract
Aim. To compare clinical characteristics of patients with atrial fibrillation (AF) depending on renal filtration function based on a retrospective analysis of data in individual subjects of the Russian Federation (RF).Material and methods. The information was taken from the Webiomed predictive analytics platform, including 80775 patients with AF (men, 42,5%, mean age, 70,0±14,3 years) who underwent outpatient and/or inpatient treatment in medical organizations in 6 Russian subjects in 2016-2019 with data on blood creatinine levels. For comparative analysis, the ranges of estimated glomerular filtration rate (eGFR) were selected: ≥60 ml/min/1,73 m2, 30–59 ml/min/1,73 m2, and 2.Results. The analysis showed that 45128 (55,9%) patients were characterized by eGFR 2, of which in 35212 (78%) patients eGFR was in the range of 30-59 ml/min/1,73 m2, in 9916 (22%) — 2. Patients with eGFR 2 compared with those with eGFR ≥60 ml/min/1,73 m2 were older (75,4±10,9 vs 63,0±15,2 years, p2 in the age ranges ≤64 years and 65-74 years had a higher incidence of IS and MI compared with patients with eGFR ≥60 ml/min/173 m2. The frequency of ICH on warfarin compared with direct oral anticoagulants was significantly higher in the subgroup with eGFR of 30-59 ml/min/1,73 m2 (1,1 vs 0,7%, pConclusion. Patients with AF and eGFR 2 are characterized by greater comorbidity, a higher incidence of IS, MI and ICH compared with patients with AF and eGFR ≥60 ml/min/1,73 m2, while ACT prescription rate as of 2016-2019 in some Russian subjects was unsatisfactory. This emphasizes the need to optimize risk stratification, ACT and algorithms for the prevention of atherothrombotic events, as well as the development of nephroprotective strategies to reduce the rate of progression of renal dysfunction in this cohort of patients.Keywords
This publication has 29 references indexed in Scilit:
- Management and 1‐Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD‐AF RegistryJournal of the American Heart Association, 2019
- Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF StudyRational Pharmacotherapy in Cardiology, 2018
- Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AFJournal of the American Heart Association, 2018
- Chronic Kidney Disease as Basis of High Thrombotic and Bleeding Risk in Patients With Atrial Fibrillation: Place of Oral AnticoagulantsKardiologiia, 2018
- Practice of managing patients with atrial fibrillation: A real situation as exemplified by the Moscow R egistry of 2009–2015Russian Heart Journal, 2017
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuumTerapevticheskii arkhiv, 2016
- Systematic review and meta-analysis of chronic kidney disease as predictor of atrial fibrillation recurrence following catheter ablationCardiology Journal, 2014
- CARDIOVASCULAR RISK AND CHRONIC KIDNEY DISEASE: CARDIO-NEPHROPROTECTION STRATEGIESRussian Journal of Cardiology, 2014
- Renal Dysfunction as a Predictor of Stroke and Systemic Embolism in Patients With Nonvalvular Atrial FibrillationCirculation, 2013